Another retrospective study of 152 ovarian cancer specimens (serous, endometrioid, mucinous and clear cell) further corroborated this by showing CIP2A overexpression in 65.79% of samples tested (118). This evidence concerns the gene CIP2A and ovarian carcinoma.